Virbac Animal Health India is a finished-dose manufacturer based in India. It appears in 16 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Customs aggregates show $1.1M of exports covering 192 molecules to 5 destinations in 2025.
| Regulator | Filings | GMP certificates |
|---|---|---|
| Health Canada | 16 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $143K | 2 |
| 2025 | Not reported | $1.1M | 5 |
| 2024 | Not reported | $1.6M | 7 |
| 2023 | Not reported | $761K | 4 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.
Choose your molecules and target markets. Virbac Animal Health India comes back tiered against every other supplier able to file there.
Start for free